Irish Government to Consider Ban on Disposable E-Cigarettes

Sep.10.2024
Irish Government to Consider Ban on Disposable E-Cigarettes
Irish Cabinet to consider banning sale of disposable e-cigarettes amid concerns over public health and environmental impact.

According to a report by the Irish Times on September 10, the Irish government cabinet will consider a proposal to ban the sale of disposable e-cigarettes.


Health Minister Stephen Donnelly is expected to receive government approval to begin drafting legislation to ban the sale, manufacture, or import of disposable e-cigarettes in Ireland.


Donald plans to introduce this ban from the perspective of environmental protection and public health. The cabinet will consider a report pointing out that disposable e-cigarettes are relatively cheap and have a high usage rate among young people. Additionally, these products can cause harm to the environment if not disposed of properly, so their plastic and batteries should be recycled correctly.


Minister Donald expressed concern that the nicotine content in products sold in the country exceeded the allowable maximum level of 20 milligrams.


The legislation will also ban flavored nicotine products that appeal to children. It is estimated that there are up to 15,000 flavor combinations on the market. The law will prohibit advertising e-cigarette products outside of specialty stores and restrict colorful packaging. Donnelly will also update the Cabinet on future predictions for the number of general practitioners in Ireland over the next few years, expecting an increase from about 7 per 10,000 people to 9 to 10.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia HB 308 would overhaul tobacco and nicotine rules, and creating a vape “white list”
Virginia’s HB 308 (Substitute) proposes a sweeping rewrite of how tobacco, nicotine and certain smokable hemp products are regulated, consolidating enforcement under ABC, requiring retailer permits, creating a vape product directory and escalating penalties for violations.
Feb.06 by 2FIRSTS.ai
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Global Forum on Nicotine 2026 to explore why prohibition of safer nicotine products risks, and does not protect, public health
Mar.12
Philippines DTI Floats Blanket Ban on Open-Pod Vapes and E-Liquids, Seeks Public Input
Philippines DTI Floats Blanket Ban on Open-Pod Vapes and E-Liquids, Seeks Public Input
Philippines’ Department of Trade and Industry (DTI) is inviting stakeholder feedback on a draft Department Administrative Order (DAO) that would impose a blanket ban on open vape pods and e-liquids—covering use, manufacturing, importation, and distribution.
Jan.29 by 2FIRSTS.ai
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
Product | VOZOL’s New E-Cigarette Appears on Middle East Social Media, Touted at 40,000 Puffs with Dual Mesh Coils and Dual Modes
VOZOL has recently promoted its MAGIC FLEX 40000 e-cigarette on its official Iraq social media account, using mainly Arabic-language posts and listing Baghdad as the account location. The campaign highlights a detachable/separate battery, the ability to switch flavors at will, ECO/POWER dual-mode operation, and a display-based user interface.
Jan.27 by 2FIRSTS.ai
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
PMI Launches Mass Production of ZYN at $600M Aurora Manufacturing Hub
Philip Morris International (PMI), through its subsidiary Swedish Match, has started large-scale production at a 600,000-square-foot ZYN nicotine pouch facility in Aurora, Colorado. The $600 million investment makes the site one of three ZYN manufacturing plants in the United States and the company’s second U.S. facility after Owensboro, Kentucky.
PMI
Feb.21